The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

NVIDIA Corporation (NASDAQ:NVDA) is one of the 10 Best Semiconductor Stocks to Buy According to Reddit. NVIDIA Corporation ...